SCHEMBL6672676

SCHEMBL6672676

N[C@H]1C(=O)O[C@H]2CCCC[C@@H]21

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 12/20 0.46
F2 P00734 10/20 0.46
CTRC Q99895 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668345 1.00 PRSS1 (0.46) PRSS1F2CTRC
SCHEMBL6668341 1.00 PRSS1 (0.46) PRSS1F2CTRC
SCHEMBL7886105 1.00 PRSS1 (0.46) PRSS1F2CTRC
SCHEMBL3575830 0.98 PRSS1 (0.44) PRSS1F2CTRC
SCHEMBL3578767 0.98 PRSS1 (0.44) PRSS1F2CTRC
SCHEMBL5529318 0.76 PRSS1 (0.44) PRSS1F2CTRC
SCHEMBL25724111 0.72 PRSS1 (0.42) PRSS1F2CTRC
SCHEMBL14466987 0.71 PRSS1 (0.49) PRSS1F2CTRC
SCHEMBL13293839 0.71 PRSS1 (0.49) PRSS1F2CTRC
SCHEMBL12836373 0.71 PRSS1 (0.49) PRSS1F2CTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270562-B1 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof SERVIER LAB (FR) 2004-09-22 EP disclosed
US-6593312-B2 Hypoglycemic agents; antidiabetic agents; dietetics LES LABORATOIRES SERVIER (FR) 2003-07-15 US disclosed
EP-1270562-A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof Les Laboratoires Servier (FR) 2003-01-02 EP disclosed
US-20030004138-A1 Cyclic a-amino-y hydroxyamide compounds LES LABORATOIRES SERVIER (FR) 2003-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004138-A1 Cyclic a-amino-y hydroxyamide compounds GPR119, SLC5A1, SLC5A2 PRSS1 4257/4885F2 3145/4885CTRC 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.